CIDRAP newsletters options
Gavi's expanded vaccine portfolio fits its goal of ensuring that lower-income countries have access to key vaccines as soon as possible.
The test can detect bacteria in a urine sample in 15 minutes and identify the right antibiotic in as little as 45 minutes.
The Netherlands had the most detections.
A negative result indicates low immunity, but a positive result doesn't necessarily indicate sufficient immunity.
The two studies indicate that continuous infusions of beta-lactam antibiotics reduce the risk of mortality in critically ill sepsis patients.
States could reduce disparities by populating forms with enrollee data or allowing more time to return forms, the authors say.
The virus used in the experiment was A 2.3.4.4b, a highly pathogenic H5N1 avian flu virus isolated from a human patient in Chile in 2023.
Wisconsin hasn't reported any dairy herd outbreaks, but three neighboring states have.
The CDC and FDA are also investigating a second similar Salmonella outbreak that has sickened 184 people in 24 states.
Cuba is experiencing Oropouche virus infections for the first time, part of rising activity in the Americas.
Previous COVID-19 infection was associated with an almost 50% reduced risk of a symptomatic cold.
Rates of events such as all-cause death, heart attack, stroke, and hospitalization for chest pain, heart failure, and respiratory infections were comparable.
Officials reported 36 more detections in mice, as well as 4 more H5N1 positives in cats.
The NASEM emphasizes that long COVID can follow asymptomatic, mild, or severe cases of COVID-19.
The results suggest that children with severe SARS-CoV-2 or MIS-C and severe neurologic disorders may be at high risk for long-term impairment, the authors say.
The company said a combo vaccine might help bridge gaps in vaccine coverage while simplifying vaccination.
The child in India had been exposed to poultry, which are known to carry the virus in multiple countries.
The rate of mechanical ventilation use was also two- to three-fold higher in 2022-2023 compared with prepandemic years.
GARDP will provide Bugworks up to $20 million in financial and technical support to develop BWC0977, a compound that targets difficult-to-treat pathogens.
An analysis of ED visits for pediatric UTIs from 2011 to 2020 found increasing use of first-generation cephalosporins.
